Product Code: GVR-4-68040-293-3
Spatial Transcriptomics Market Growth & Trends:
The global spatial transcriptomics market is anticipated to reach USD 902.2 million by 2030, exhibiting a CAGR of 15.23% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising potential of spatial omics analysis as a cancer tool increased the demand for spatial transcriptomics, continuous advancements in spatial transcriptomics technologies, and the expanding field of drug discovery and development are anticipated to increase the demand for spatial transcriptomics over the forecast period.
Moreover, there is continued integration of AI and ML in various industries, including healthcare, finance, and manufacturing. The industry is witnessing advancements in natural language processing, computer vision, and reinforcement learning. In healthcare, AI-driven spatial analysis can enhance the precision of mapping disease outbreaks, optimizing resource allocation, and predicting patient outcomes based on geographical data. Thus, as AI and ML continue to evolve, their application in spatial analysis is expected to drive significant growth and innovation across various industries, leveraging the power of spatial data to enhance decision-making and operational efficiency. Thereby impelling the growth of the spatial transcriptomics market over the foreseeable future.
However, analyzing spatial transcriptomics data requires specialized computational tools and expertise. The interpretation of large-scale spatial datasets presents challenges related to data management, integration, and visualization. The high costs associated with instruments, reagents, and data analysis can pose a barrier to entry for some researchers and is anticipated to hamper the growth of the market.
Spatial Transcriptomics Market Report Highlights:
- The consumables segment dominated the product segment with the highest revenue share of 52.73% in 2023. This is attributed to the high product penetration and high usage of kits & reagents. On the other hand, software is expected to grow at the fastest rate over the forecast period.
- The sequencing-based methods segment held the largest market share of 53.61% in 2023 for the technology segment and is anticipated to grow at the fastest rate over the forecast period. This is attributed to the growing interest in using spatial transcriptomics for cancer research, developmental biology, neuroscience, and disease pathology.
- Based on workflow, instrumental analysis dominated the segment with the largest revenue share of 47.02% in 2023 and is anticipated to grow at the highest CAGR over the forecast period. However, sample preparation is expected to grow significantly from 2024 to 2030.
- Based on sample type, FFPE dominated the segment with the largest revenue share of 63.30% in 2023. On the other hand, fresh frozen is expected to grow at the fastest rate over the forecast period.
- Based on end use, translational research dominated the segment with the largest revenue share of 56.63% in 2023 and is anticipated to grow at the highest CAGR over the forecast period. This is attributed to the growing R&D activities, increasing demand for personalized medicines, and growing technological advancements.
- The North American region dominated the market share of 57.73% in 2023 due to its robust healthcare infrastructure, high adoption rates of advanced medical technologies, and significant investments in biopharmaceutical research and development. On the other hand, Asia Pacific anticipated growing at the highest CAGR over the forecast period.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Product
- 1.2.2. Technology
- 1.2.3. Workflow
- 1.2.4. Sample Type
- 1.2.5. End-use
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Emerging potential of spatial omic analysis as a cancer diagnostic tool
- 3.2.1.2. Advent of fourth generation of sequencing (in situ sequencing)
- 3.2.1.3. Increasing market competition due to emerging players
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of instruments
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. Spatial Transcriptomics Market: Product Business Analysis
- 4.1. Product Segment Dashboard
- 4.2. Global Spatial Transcriptomics Market Product Movement Analysis
- 4.3. Global Spatial Transcriptomics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Instrument
- 4.4.1. Global Instrument Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. By Mode
- 4.4.2.1. Automated
- 4.4.2.1.1. Global Automated Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2.2. Semi-automated
- 4.4.2.2.1. Global Semi-automated Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2.3. Manual
- 4.4.2.3.1. Global Manual Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3. By Type
- 4.4.3.1. Sequencing Platforms
- 4.4.3.1.1. Global Sequencing Platforms Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3.2. IHC
- 4.4.3.2.1. Global IHC Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3.3. Microscopy
- 4.4.3.3.1. Global Microscopy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3.4. Flow Cytometry
- 4.4.3.4.1. Global Flow Cytometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3.5. Mass Spectrometry
- 4.4.3.5.1. Global Mass Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3.6. Others
- 4.4.3.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Consumables
- 4.5.1. Global Consumables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Software
- 4.6.1. Global Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.2. Bioinformatics Tools
- 4.6.2.1. Global Bioinformatics Tools Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.3. Imaging Tools
- 4.6.3.1. Global Imaging Tools Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.4. Storage and Management Databases
- 4.6.4.1. Global Storage and Management Databases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Spatial Transcriptomics Market: Technology Business Analysis
- 5.1. Technology Segment Dashboard
- 5.2. Global Spatial Transcriptomics Market Technology, Movement Analysis
- 5.3. Global Spatial Transcriptomics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
- 5.4. Sequencing-based Methods
- 5.4.1. Global Sequencing-based Methods Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.2. Laser Capture Microdissection (LCM)
- 5.4.2.1. Global Laser Capture Microdissection (LCM) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.3. Transcriptome In-Vivo Analysis (TIVA)
- 5.4.3.1. Global Transcriptome In-Vivo Analysis (TIVA) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.4. In Situ Sequencing
- 5.4.4.1. Global In Situ Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.5. Microtomy Sequencing
- 5.4.5.1. Global Microtomy Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. IHC
- 5.5.1. Global IHC Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Microscopy-based RNA Imaging Techniques
- 5.6.1. Global Microscopy-based RNA Imaging Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.2. Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH)
- 5.6.2.1. Global Single Molecule RNA Fluorescence In-Situ Hybridization (smFISH) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.3. Padlock Probes/ Rolling Circle Amplification
- 5.6.3.1. Global Padlock Probes/ Rolling Circle Amplification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.4. Branched DNA Probes
- 5.6.4.1. Global Branched DNA Probes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Spatial Transcriptomics Market: Workflow Business Analysis
- 6.1. Workflow Segment Dashboard
- 6.2. Global Spatial Transcriptomics Market Workflow Movement Analysis
- 6.3. Global Spatial Transcriptomics Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
- 6.4. Sample Preparation
- 6.4.1. Global Sample Preparation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Instrumental Analysis
- 6.5.1. Global Instrumental Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Data Analysis
- 6.6.1. Global Data Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Spatial Transcriptomics Market: sample Type Business Analysis
- 7.1. Sample Type Segment Dashboard
- 7.2. Global Spatial Transcriptomics Market Sample Type Movement Analysis
- 7.3. Global Spatial Transcriptomics Market Size & Trend Analysis, by Sample Type, 2018 to 2030 (USD Million)
- 7.4. FFPE
- 7.4.1. Global FFPE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Fresh Frozen
- 7.5.1. Global Fresh Frozen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Spatial Transcriptomics Market: End-use Business Analysis
- 8.1. End-use Segment Dashboard
- 8.2. Global Spatial Transcriptomics Market End-use Movement Analysis
- 8.3. Global Spatial Transcriptomics Market Size & Trend Analysis, by End-use , 2018 to 2030 (USD Million)
- 8.4. Translational Research
- 8.4.1. Global Translational Research Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5. Academic Customers
- 8.5.1. Global Academic Customers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6. Diagnostic Customers
- 8.6.1. Global Diagnostic Customers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7. Pharmaceutical Manufacturer
- 8.7.1. Global Pharmaceutical Manufacturer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Spatial Transcriptomics Market: Regional Estimates & Trend Analysis by Product, Technology, Workflow, Sample Type, & End-use
- 9.1. Regional Dashboard
- 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 9.3. North America
- 9.3.1. North America Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.2. U.S.
- 9.3.2.1. Key Country Dynamics
- 9.3.2.2. Competitive Scenario
- 9.3.2.3. Regulatory Framework
- 9.3.2.4. U.S. Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.3. Canada
- 9.3.3.1. Key Country Dynamics
- 9.3.3.2. Competitive Scenario
- 9.3.3.3. Regulatory Framework
- 9.3.3.4. Canada Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.4. Mexico
- 9.3.4.1. Key Country Dynamics
- 9.3.4.2. Competitive Scenario
- 9.3.4.3. Regulatory Framework
- 9.3.4.4. Mexico Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4. Europe
- 9.4.1. Europe Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.2. UK
- 9.4.2.1. Key Country Dynamics
- 9.4.2.2. Competitive Scenario
- 9.4.2.3. Regulatory Framework
- 9.4.2.4. UK Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.3. Germany
- 9.4.3.1. Key Country Dynamics
- 9.4.3.2. Competitive Scenario
- 9.4.3.3. Regulatory Framework
- 9.4.3.4. Germany Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.4. France
- 9.4.4.1. Key Country Dynamics
- 9.4.4.2. Competitive Scenario
- 9.4.4.3. Regulatory Framework
- 9.4.4.4. France Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.5. Italy
- 9.4.5.1. Key Country Dynamics
- 9.4.5.2. Competitive Scenario
- 9.4.5.3. Regulatory Framework
- 9.4.5.4. Italy Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.6. Spain
- 9.4.6.1. Key Country Dynamics
- 9.4.6.2. Competitive Scenario
- 9.4.6.3. Regulatory Framework
- 9.4.6.4. Spain Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.7. Denmark
- 9.4.7.1. Key Country Dynamics
- 9.4.7.2. Competitive Scenario
- 9.4.7.3. Regulatory Framework
- 9.4.7.4. Denmark Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.8. Sweden
- 9.4.8.1. Key Country Dynamics
- 9.4.8.2. Competitive Scenario
- 9.4.8.3. Regulatory Framework
- 9.4.8.4. Sweden Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.9. Norway
- 9.4.9.1. Key Country Dynamics
- 9.4.9.2. Competitive Scenario
- 9.4.9.3. Regulatory Framework
- 9.4.9.4. Norway Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5. Asia Pacific
- 9.5.1. Asia Pacific Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.2. Japan
- 9.5.2.1. Key Country Dynamics
- 9.5.2.2. Competitive Scenario
- 9.5.2.3. Regulatory Framework
- 9.5.2.4. Japan Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.3. China
- 9.5.3.1. Key Country Dynamics
- 9.5.3.2. Competitive Scenario
- 9.5.3.3. Regulatory Framework
- 9.5.3.4. China Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.4. India
- 9.5.4.1. Key Country Dynamics
- 9.5.4.2. Competitive Scenario
- 9.5.4.3. Regulatory Framework
- 9.5.4.4. India Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.5. Australia
- 9.5.5.1. Key Country Dynamics
- 9.5.5.2. Competitive Scenario
- 9.5.5.3. Regulatory Framework
- 9.5.5.4. Australia Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.6. Thailand
- 9.5.6.1. Key Country Dynamics
- 9.5.6.2. Competitive Scenario
- 9.5.6.3. Regulatory Framework
- 9.5.6.4. Thailand Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.7. South Korea
- 9.5.7.1. Key Country Dynamics
- 9.5.7.2. Competitive Scenario
- 9.5.7.3. Regulatory Framework
- 9.5.7.4. South Korea Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6. Latin America
- 9.6.1. Latin America Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.2. Brazil
- 9.6.2.1. Key Country Dynamics
- 9.6.2.2. Competitive Scenario
- 9.6.2.3. Regulatory Framework
- 9.6.2.4. Brazil Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.3. Argentina
- 9.6.3.1. Key Country Dynamics
- 9.6.3.2. Competitive Scenario
- 9.6.3.3. Regulatory Framework
- 9.6.3.4. Argentina Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.7. MEA
- 9.7.1. MEA Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.7.2. South Africa
- 9.7.2.1. Key Country Dynamics
- 9.7.2.2. Competitive Scenario
- 9.7.2.3. Regulatory Framework
- 9.7.2.4. South Africa Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.7.3. Saudi Arabia
- 9.7.3.1. Key Country Dynamics
- 9.7.3.2. Competitive Scenario
- 9.7.3.3. Regulatory Framework
- 9.7.3.4. Saudi Arabia Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.7.4. UAE
- 9.7.4.1. Key Country Dynamics
- 9.7.4.2. Competitive Scenario
- 9.7.4.3. Regulatory Framework
- 9.7.4.4. UAE Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.7.5. Kuwait
- 9.7.5.1. Key Country Dynamics
- 9.7.5.2. Competitive Scenario
- 9.7.5.3. Regulatory Framework
- 9.7.5.4. Kuwait Spatial Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
- 10.1. Participant Categorization
- 10.2. Strategy Mapping
- 10.3. Company Market Position Analysis, 2023
- 10.4. Participant's Overview
- 10.4.1. Illumina, Inc.
- 10.4.1.1. Overview
- 10.4.1.2. Financial Performance
- 10.4.1.3. Product Benchmarking
- 10.4.1.4. Strategic Initiatives
- 10.4.2. NanoString Technologies, Inc.
- 10.4.2.1. Overview
- 10.4.2.2. Financial Performance
- 10.4.2.3. Product Benchmarking
- 10.4.2.4. Strategic Initiatives
- 10.4.3. 10x Genomics.
- 10.4.3.1. Overview
- 10.4.3.2. Financial Performance
- 10.4.3.3. Product Benchmarking
- 10.4.3.4. Strategic Initiatives
- 10.4.4. Cantata Bio
- 10.4.4.1. Overview
- 10.4.4.2. Financial Performance
- 10.4.4.3. Product Benchmarking
- 10.4.4.4. Strategic Initiatives
- 10.4.5. Bruker
- 10.4.5.1. Overview
- 10.4.5.2. Financial Performance
- 10.4.5.3. Product Benchmarking
- 10.4.5.4. Strategic Initiatives
- 10.4.6. EVOSEP
- 10.4.6.1. Overview
- 10.4.6.2. Financial Performance
- 10.4.6.3. Product Benchmarking
- 10.4.6.4. Strategic Initiatives
- 10.4.7. Shimadzu Corporation
- 10.4.7.1. Overview
- 10.4.7.2. Financial Performance
- 10.4.7.3. Product Benchmarking
- 10.4.7.4. Strategic Initiatives
- 10.4.8. Waters
- 10.4.8.1. Overview
- 10.4.8.2. Financial Performance
- 10.4.8.3. Product Benchmarking
- 10.4.8.4. Strategic Initiatives
- 10.4.9. Horizon Discovery Group plc
- 10.4.9.1. Overview
- 10.4.9.2. Financial Performance
- 10.4.9.3. Product Benchmarking
- 10.4.9.4. Strategic Initiatives
- 10.4.10. Bio-Techne
- 10.4.10.1. Overview
- 10.4.10.2. Financial Performance
- 10.4.10.3. Product Benchmarking
- 10.4.10.4. Strategic Initiatives
Chapter 11. Analyst View